BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23593011)

  • 1. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB.
    Garding A; Bhattacharya N; Claus R; Ruppel M; Tschuch C; Filarsky K; Idler I; Zucknick M; Caudron-Herger M; Oakes C; Fleig V; Keklikoglou I; Allegra D; Serra L; Thakurela S; Tiwari V; Weichenhan D; Benner A; Radlwimmer B; Zentgraf H; Wiemann S; Rippe K; Plass C; Döhner H; Lichter P; Stilgenbauer S; Mertens D
    PLoS Genet; 2013 Apr; 9(4):e1003373. PubMed ID: 23593011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia and 13q14: miRs and more.
    Mertens D; Philippen A; Ruppel M; Allegra D; Bhattacharya N; Tschuch C; Wolf S; Idler I; Zenz T; Stilgenbauer S
    Leuk Lymphoma; 2009 Mar; 50(3):502-5. PubMed ID: 19347735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.
    Mertens D; Wolf S; Tschuch C; Mund C; Kienle D; Ohl S; Schroeter P; Lyko F; Döhner H; Stilgenbauer S; Lichter P
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7741-6. PubMed ID: 16684883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
    Migliazza A; Bosch F; Komatsu H; Cayanis E; Martinotti S; Toniato E; Guccione E; Qu X; Chien M; Murty VV; Gaidano G; Inghirami G; Zhang P; Fischer S; Kalachikov SM; Russo J; Edelman I; Efstratiadis A; Dalla-Favera R
    Blood; 2001 Apr; 97(7):2098-104. PubMed ID: 11264177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia.
    Liu Y; Corcoran M; Rasool O; Ivanova G; Ibbotson R; Grandér D; Iyengar A; Baranova A; Kashuba V; Merup M; Wu X; Gardiner A; Mullenbach R; Poltaraus A; Hultström AL; Juliusson G; Chapman R; Tiller M; Cotter F; Gahrton G; Yankovsky N; Zabarovsky E; Einhorn S; Oscier D
    Oncogene; 1997 Nov; 15(20):2463-73. PubMed ID: 9395242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia.
    Mertens D; Wolf S; Schroeter P; Schaffner C; Döhner H; Stilgenbauer S; Lichter P
    Blood; 2002 Jun; 99(11):4116-21. PubMed ID: 12010815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13q14 deletions in CLL involve cooperating tumor suppressors.
    Palamarchuk A; Efanov A; Nazaryan N; Santanam U; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
    Blood; 2010 May; 115(19):3916-22. PubMed ID: 20071661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
    Oncogene; 1998 Apr; 16(14):1891-7. PubMed ID: 9583687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions.
    Wolf S; Mertens D; Schaffner C; Korz C; Döhner H; Stilgenbauer S; Lichter P
    Hum Mol Genet; 2001 Jun; 10(12):1275-85. PubMed ID: 11406609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines.
    Lia M; Carette A; Tang H; Shen Q; Mo T; Bhagat G; Dalla-Favera R; Klein U
    Blood; 2012 Mar; 119(13):2981-90. PubMed ID: 22174151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions.
    Tolomeo D; Agostini A; Solimando AG; Cunsolo CL; Cimarosto L; Palumbo O; Palumbo P; Carella M; Hernández-Sánchez M; Hernández-Rivas JM; Storlazzi CT
    Cancer Genet; 2023 Apr; 272-273():16-22. PubMed ID: 36641997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transcription map of the minimally deleted region from 13q14 in B-cell chronic lymphocytic leukemia as defined by large scale sequencing of the 650 kb critical region.
    Kitamura E; Su G; Sossey-Alaoui K; Malaj E; Lewis J; Pan HQ; Hawthorn L; Roe B; Cowell JK
    Oncogene; 2000 Nov; 19(50):5772-80. PubMed ID: 11126364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene.
    Bullrich F; Fujii H; Calin G; Mabuchi H; Negrini M; Pekarsky Y; Rassenti L; Alder H; Reed JC; Keating MJ; Kipps TJ; Croce CM
    Cancer Res; 2001 Sep; 61(18):6640-8. PubMed ID: 11559527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis.
    Xu W; Wang B; Cai Y; Guo C; Liu K; Yuan C
    Curr Pharm Des; 2021; 27(20):2337-2343. PubMed ID: 33106136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.